Abstract
We performed a genome-wide association study for chronic obstructive pulmonary disease (COPD) in three population cohorts, including 2,940 cases and 1,380 controls who were current or former smokers with normal lung function. We identified a new susceptibility locus at 4q22.1 in FAM13A and replicated this association in one case-control group (n = 1,006) and two family-based cohorts (n = 3,808) (rs7671167, combined P = 1.2 × 10−11, combined odds ratio in case-control studies 0.76, 95% confidence interval 0.69–0.83).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
References
Rabe, K.F. et al. Am. J. Respir. Crit. Care Med. 176, 532–555 (2007).
Silverman, E.K. Proc. Am. Thorac. Soc. 3, 405–408 (2006).
Pillai, S.G. et al. PLoS Genet. 5, e1000421 (2009).
Fishman, A. et al. N. Engl. J. Med. 348, 2059–2073 (2003).
Bell, B. et al. Aging Hum. Dev. 3, 5–17 (1972).
Wilk, J.B. et al. PLoS Genet. 5, e1000429 (2009).
Vestbo, J. et al. Eur. Respir. J. 31, 869–873 (2008).
Cohen, M. et al. Genomics 84, 374–383 (2004).
Chi, J.T. et al. PLoS Med. 3, e47 (2006).
Wade, K.C. et al. Am. J. Respir. Cell Mol. Biol. 34, 727–737 (2006).
Wright, J.M. et al. Am. J. Respir. Cell Mol. Biol. 35, 327–336 (2006).
Hancock, D.B. et al. Nat. Genet. 42, 45–52 (2010).
Repapi, E. et al. Nat. Genet. 42, 36–44 (2010).
Wellcome Trust Case Control Consortium. Nature 447, 661–678 (2007).
Thorgeirsson, T.E. et al. Nature 452, 638–642 (2008).
Acknowledgements
This work was supported by US National Institutes of Health (NIH) grants R01 HL075478, R01 HL084323, P01 HL083069, U01 HL089856 (E.K.S.), K12HL089990 (M.H.C) and U01 HL089897 (J.D.C.). The National Emphysema Treatment Trial was supported by the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services and the Agency for Healthcare Research and Quality. The Normative Aging Study is supported by the Cooperative Studies Program/ERIC of the US Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). The Norway cohort, the ECLIPSE study (Clinicaltrials.gov identifier NCT00292552; GSK Code SCO104960) and the ICGN study are funded by GlaxoSmithKline. Further acknowledgments are given in the Supplementary Note.
Author information
Authors and Affiliations
Contributions
Study design: E.K.S., M.H.C., A.A.L., D.S., S.G.P., X.K., W.H.A., R.T.-S., D.A.L., P.B., A.G., J.R.M., T.H.B., E.A.R., B.J.M., J.E.H., J.D.C., C.P.H. and D.L.D. Sample collection and phenotyping: A.A.L., D.S., S.G.P., X.K., W.H.A., R.T.-S., D.A.L., P.B., A.G., E.A.R., B.J.M., J.D.C., E.K.S. Genotyping: N.B., B.J.K., M.H.C., S.G.P., X.K. Informatics: M.H.C., J.S.S., J.P.Z., B.J.K., N.B. Statistical analysis: M.H.C., C.L., S.W., E.K.S. Manuscript writing: M.H.C., G.M.H., E.K.S. All authors reviewed and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
E.K.S. has received grant support and consulting and speaker's fees from GlaxoSmithKline, consulting and speaker's fees from Astra-Zeneca and speaker's fees from Bayer and Wyeth. D.A.L. has received grant support, lecture fees and consultancy fees from GlaxoSmithKline. S.G.P, X.Q.K., W.H.A. and R.M.T. are employees of GlaxoSmithKline.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Note, Supplementary Figures 1–3 and Supplementary Tables 1–4 (PDF 466 kb)
Rights and permissions
About this article
Cite this article
Cho, M., Boutaoui, N., Klanderman, B. et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 42, 200–202 (2010). https://doi.org/10.1038/ng.535
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.535
This article is cited by
-
Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Respiratory Research (2024)
-
X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study
Respiratory Research (2023)
-
FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers
BMC Cancer (2023)
-
Family with sequence similarity 13 member A mediates TGF-β1-induced EMT in small airway epithelium of patients with chronic obstructive pulmonary disease
Respiratory Research (2021)
-
The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease
Clinical Reviews in Allergy & Immunology (2021)